The alternatives
Rx.com scores 82/100 (grade B−, ranked #35) on The Verdict Score. Here are the top-rated GLP-1 providers we'd weigh against it — same six-factor rubric, and no score is adjusted for payment.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to Rx.com's 82, and our Rx.com vs CoreAge Rx ruling sets the two out factor by factor.
REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.
REMEVi scores 83/100 to Rx.com's 82; our REMEVi ruling in full has the pricing conditions and the caveats in detail.
Will prescribe brand Wegovy, Ozempic or Mounjaro when clinically appropriate, with unlimited round-the-clock access to its clinical team.
Synergy Rx scores 79/100 to Rx.com's 82; the full Synergy Rx review has the pricing conditions and the caveats in detail.
Cheap semaglutide and nationwide coverage, with a tirzepatide markup and no LegitScript listing.
Live Vital scores 83/100 to Rx.com's 82; the full Live Vital review has the pricing conditions and the caveats in detail.
A recognizable coaching-forward brand undercut by a limited state footprint and no LegitScript listing.
Mochi Health scores 81/100 to Rx.com's 82; our full write-up on Mochi Health has the pricing conditions and the caveats in detail.
A flat-fee compounded pioneer — simple model, but priced at the higher end now.
Henry Meds scores 84/100 to Rx.com's 82; the full Henry Meds review has the pricing conditions and the caveats in detail.
A men's-health-focused program with a steep tirzepatide price, a partial state map and no LegitScript listing.
Fella Health scores 81/100 to Rx.com's 82; our Fella Health ruling in full has the pricing conditions and the caveats in detail.
See the complete rankings or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.